These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15937348)

  • 1. Image analysis and data management of ELISPOT assay results.
    Lehmann PV
    Methods Mol Biol; 2005; 302():117-32. PubMed ID: 15937348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resolution as a key feature to perform accurate ELISPOT measurements using Zeiss KS ELISPOT readers.
    Malkusch W
    Methods Mol Biol; 2005; 302():133-50. PubMed ID: 15937349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective, user-independent ELISPOT data analysis based on scientifically validated principles.
    Zhang W; Lehmann PV
    Methods Mol Biol; 2012; 792():155-71. PubMed ID: 21956509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization and validation issues of the ELISPOT assay.
    Janetzki S; Cox JH; Oden N; Ferrari G
    Methods Mol Biol; 2005; 302():51-86. PubMed ID: 15937345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2 absorption affects IFN-gamma and IL-5, but not IL-4 producing memory T cells in double color cytokine ELISPOT assays.
    Quast S; Zhang W; Shive C; Kovalovski D; Ott PA; Herzog BA; Boehm BO; Tary-Lehmann M; Karulin AY; Lehmann PV
    Cell Immunol; 2005 Sep; 237(1):28-36. PubMed ID: 16256965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-detachment solution can reduce background staining in the ELISPOT assay.
    Grant A; Palzer S; Hartnett C; Bailey T; Tsang M; Kalyuzhny AE
    Methods Mol Biol; 2005; 302():87-94. PubMed ID: 15937346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
    Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y
    Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma ELISPOT assay for the quantitative measurement of antigen-specific murine CD8+ T-cells.
    Cole GA
    Methods Mol Biol; 2005; 302():191-204. PubMed ID: 15937353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT.
    Ryan JE; Ovsyannikova IG; Poland GA
    Methods Mol Biol; 2005; 302():207-18. PubMed ID: 15937354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of interferon-gamma ELISPOT in monitoring immune responses in humans.
    Matijevic M; Urban RG
    Methods Mol Biol; 2005; 302():237-52. PubMed ID: 15937356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemistry and biology of the ELISPOT assay.
    Kalyuzhny AE
    Methods Mol Biol; 2005; 302():15-31. PubMed ID: 15937343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials.
    Moodie Z; Huang Y; Gu L; Hural J; Self SG
    J Immunol Methods; 2006 Aug; 315(1-2):121-32. PubMed ID: 16959262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feline cytokine ELISPOT: issues in assay development.
    Nordone SK; Stevens R; LaVoy AS; Dean GA
    Methods Mol Biol; 2005; 302():167-78. PubMed ID: 15937351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring--even in hands of ELISPOT-inexperienced investigators.
    Zhang W; Caspell R; Karulin AY; Ahmad M; Haicheur N; Abdelsalam A; Johannesen K; Vignard V; Dudzik P; Georgakopoulou K; Mihaylova A; Silina K; Aptsiauri N; Adams V; Lehmann PV; McArdle S
    J Immunotoxicol; 2009 Dec; 6(4):227-34. PubMed ID: 19908941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorospot assay: methodological analysis.
    Gazagne A; Malkusch W; Vingert B; Fridman WH; Tartour E
    Methods Mol Biol; 2005; 302():289-96. PubMed ID: 15937359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring T-cell function in animal models of tuberculosis by ELISPOT.
    Lazarevic V; Pawar S; Flynn J
    Methods Mol Biol; 2005; 302():179-90. PubMed ID: 15937352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical analysis of ELISPOT assays.
    Dittrich M; Lehmann PV
    Methods Mol Biol; 2012; 792():173-83. PubMed ID: 21956510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELISPOT cell rescue.
    Meiklejohn DA; Karlsson RK; Karlsson AC; Chapman JM; Nixon DF; Schweighardt B
    J Immunol Methods; 2004 May; 288(1-2):135-47. PubMed ID: 15183092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of cytokine release at the single cell level using the ELISPOT assay.
    Cox JH; Ferrari G; Janetzki S
    Methods; 2006 Apr; 38(4):274-82. PubMed ID: 16473524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency analysis of HBsAg-specific B lymphocytes in high-responder individuals to recombinant hepatitis B vaccine: comparison of LDA and ELISPOT assays.
    Shokrgozar MA; Sam MR; Amirkhani A; Shokri F
    Scand J Immunol; 2006 Nov; 64(5):536-43. PubMed ID: 17032247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.